Dr. Gurpreet Padda · St. Louis
Dr. Gurpreet Singh Padda, MD, MBA, MHP
Medical director of Measura, St. Louis, Missouri.
Who is Dr. Gurpreet Padda?
Dr. Gurpreet Singh Padda, MD, MBA, MHP is an interventional pain physician and anesthesiologist practicing in St. Louis. He is board certified in anesthesiology, pain medicine, interventional pain, addiction medicine and obesity medicine, and holds a Master of Business Administration and is a Metabolic Health Practitioner (MHP) with the Society of Metabolic Health Practitioners. He is a certified rater for the Montreal Cognitive Assessment.
That combination is unusual and it is the reason Measura looks the way it does. A physician who treats pain, addiction and obesity in the same population keeps meeting the same underlying problem from three directions: vascular disease, autonomic dysfunction and metabolic inflammation, all of them present long before anyone names them.
Why did Dr. Padda build Measura?
In an interventional pain practice, the patients who do worst are rarely the ones with the worst imaging. They are the ones whose metabolic and autonomic physiology is disordered — and that disorder is almost never measured, because measuring it has traditionally required a hospital laboratory, a tilt table and an afternoon.
The instruments in the Measura suite compress that into an office visit. The test library describes each one. The clinical rationale sets out why they were chosen.
Where does Dr. Padda practice in St. Louis?
Dr. Padda practices at 4477 Woodson Rd in St. Louis, Missouri, where Measura testing is performed in Suite 201. He also directs the Padda Institute, an interventional and chronic pain management practice in the same building.
Identifiers
National Provider Identifier 1427035955. Missouri medical license MD 100572. Certificate numbers are deliberately not published.
In the press
- Dr. Gurpreet Singh Padda, MD: The Fat That Inflames the Heart Is Also Burning the Nerves (EIN Presswire, November 17, 2026. Measura’s own release on the 2026 Obesity Medicine Association statement: fat mass is the load, sick fat is the chemistry, and the same inflamed fat that drives heart disease also injures nerves.
- Dr. Gurpreet Singh Padda, MD: Diabetic Neuropathy Is Treated as One Nerve Problem; It Is Three Different Problems (EIN Presswire, November 14, 2026). Timed to World Diabetes Day, this release makes the case that one neuropathy label covers three separate mechanisms, poor blood supply, sugar-bound proteins and gradual breakdown of nerve structure, and that nerve conduction testing and EMG help tell a pinched nerve from sugar damage.
- Dr. Gurpreet Singh Padda, MD on Veterans Day: The System Solved the Prescription and Did Not Solve the Pain (EIN Presswire, November 11, 2026). Dr. Padda notes for Veterans Day that the count of VA patients on high opioid doses dropped from roughly 60,000 in 2012 to a little over 35,000 by 2016, and he asks whether pain was ever measured alongside the falling doses.
- Dr. Gurpreet Singh Padda, MD: Trial Suggests PRP May Delay Knee Replacement for Patients Already on the Surgical List (EIN Presswire, October 12, 2026). Marking World Arthritis Day, he reviews a randomized trial in which 90 patients with knee osteoarthritis at grade 3 to 4 got two PRP injections and fared better on pain and function than with cortisone or an anti-inflammatory.
- Dr. Gurpreet Singh Padda, MD Puts the New Low-Carb Guideline to Work in Pain Care: Medicines Change Before Pain Does (EIN Presswire, October 7, 2026). Summarizes the Society of Metabolic Health Practitioners’ 2026 Delphi consensus guideline, in which all 18 statements cleared the 70 percent bar, and how Dr. Padda puts its baseline testing and medication checks to work for patients with chronic pain.
- Dr. Gurpreet Singh Padda, MD Publishes The Dopamine Brain: Dopamine Is Not the Pleasure Chemical We Thought (EIN Presswire, October 5, 2026). The fourth book in The Brain series, The Dopamine Brain separates wanting from liking and cites a controlled feeding study in which adults took in 508 extra calories daily on ultra-processed food without finding it more enjoyable.
- Dr. Gurpreet Singh Padda, MD Publishes ‘The Angry Gut, Your First Brain’ (EIN Presswire, September 28, 2026). His third volume, The Angry Gut, Your First Brain, coauthored by Ami Michelle Grimes, favors measured figures over famous ones, giving the surface area of the intestine as roughly 32 square meters instead of the size of a tennis court.
- Dr. Gurpreet Singh Padda, MD: Half of Diabetic Nerve Damage Causes No Symptoms, and It Still Causes Falls (EIN Presswire, September 24, 2026). Nerve damage from diabetes stays silent in up to half of cases, he explains, and the first sign may be a fall, which is why he argues for nerve testing to find these patients early.
- Dr. Gurpreet Singh Padda, MD Publishes The Pained Brain, Arguing Chronic Pain Is a Metabolic Disease the Scan Cannot See (EIN Presswire, September 21, 2026). In The Pained Brain, the second book in his series, he traces a metabolic thread through chronic pain, citing insulin resistance among nondiabetic American adults, which reached 38.4 percent by 2018 after standing at 24.8 percent in 1999.
- Dr. Gurpreet Singh Padda, MD Discusses Alzheimer’s Research, Not Just Plaque (EIN Presswire, September 21, 2026). Testing what is already measurable is the argument Dr. Padda brings to World Alzheimer’s Day, citing evidence that three B vitamins lowered brain shrinkage 53 percent among people whose homocysteine was high and that glucose uptake falls decades early.
- International Overdose Awareness Day (EIN Presswire, August 31, 2026). To mark International Overdose Awareness Day, Dr. Padda’s practice released its own patient figures, including 34 percent no longer taking opioids for pain a year after interventional treatment, and labeled them practice-reported numbers rather than trial results.
- New Book The Starved Brain by Dr. Gurpreet Padda Reframes Dementia as a Metabolic Disease of Overnutrition (EIN Presswire, July 23, 2026). The Starved Brain, his first book, treats dementia as a disease of overnutrition and sorts cognitive decline into four measurable failures, using a Missouri patient with low-normal B12 and a low omega-3 index as an example.
- FDA Advisory Committee Convenes on Peptides: Understanding What Reclassification Means (EIN Presswire, July 20, 2026). Before the FDA compounding committee reviewed seven peptides, he explained that lifting a restriction opened the door to review rather than signaling safety, and why lab-guided prescribing and physician oversight count for more after the change.
- Patients Already on the Knee Replacement Waiting List Find Platelet-Rich Plasma Outperformed Cortisone and NSAIDs (EIN Presswire, July 19, 2026). Beyond pain and function, the randomized trial behind this release tracked blood biomarkers of inflammation and cartilage breakdown, and two PRP injections came out ahead of cortisone and NSAIDs, with less opioid use, in knees already slated for replacement.
- Padda Institute Center for Interventional Pain Management Relocates to Expanded State-of-the-Art Facility (EIN Presswire, March 1, 2026). The Padda Institute moved to a larger home at 4477 Woodson Road, just under 18,000 square feet in size, where metabolic medicine now shares the building with injury rehabilitation, concussion recovery and interventional pain treatment.
Talk to someone about testing
Tell us what you are trying to find out and we will explain which Measura assessments answer that question, what each one involves, and how the results are reviewed with a clinician.
4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.
Frequently asked questions
Does Dr. Padda perform the assessments himself?
The studies are performed by trained staff; interpretation is a physician task. Supervision and staffing.
Can I see him as a patient?
Measura is a diagnostic assessment service. Clinical care is a separate conversation, and the right starting point is a phone call. What happens before your appointment.
What is his position on metabolic health and pain?
That the two are inseparable in most chronic pain patients. Why metabolic health belongs in a pain practice.
Is Dr. Padda a pain management doctor?
Yes. Dr. Gurpreet Singh Padda, MD, MBA, MHP is an interventional pain physician and anesthesiologist in St. Louis. He directs the Padda Institute, an interventional and chronic pain management practice at 4477 Woodson Rd, and he is the medical director of Measura, which performs its non-invasive testing in Suite 201 of the same building.
What is Dr. Padda board certified in?
He is board certified in anesthesiology, pain medicine, interventional pain, addiction medicine and obesity medicine. He also holds a Master of Business Administration, is a Metabolic Health Practitioner (MHP) with the Society of Metabolic Health Practitioners, and is a certified rater for the Montreal Cognitive Assessment. That mix is the reason Measura looks at vascular, autonomic and metabolic health together.
Where is Dr. Padda located in St. Louis?
Dr. Padda practices at 4477 Woodson Rd in St. Louis, Missouri. Measura testing is performed in Suite 201, and the Padda Institute pain practice he directs is in the same building. Measura is a testing service and clinical care is a separate conversation, so the right starting point for either one is a phone call.
About Dr. Padda

Dr. Gurpreet Singh Padda, MD, MBA, MHP is the medical director of Measura. He is board certified in anesthesiology, interventional pain management, addiction medicine and obesity medicine, and holds a Master of Business Administration and is a Metabolic Health Practitioner (MHP) with the Society of Metabolic Health Practitioners. He practices in St. Louis, Missouri.
His clinical work sits at the intersection this testing was built for: patients whose pain, fatigue, numbness or dizziness turn out to be driven by vascular, autonomic and metabolic problems that nobody had measured. Measura exists because he kept finding those problems late, and wanted a way to find them earlier. Read more about Dr. Padda.
Board certifications, societies and affiliations












Certificate and license numbers are deliberately not published. Dr. Padda’s National Provider Identifier is 1427035955.
Published research. His peer-reviewed record is registered under ORCID 0009-0001-0166-3186 and indexed at PubMed, OpenAlex and Semantic Scholar. His biographical record is Wikidata Q141049117.
Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, medical director of Measura. Last reviewed .